Bio SB partners with Cancer Diagnostics, 11/13

Bio SB, a molecular pathology company based in Santa Barbara, Calif., has announced that it will partner with Cancer Diagnostics Inc. to distribute the Bio SB line of IHC antibodies, chromogens, and ancillaries in the U.S. market.

“We are very excited to partner with Cancer Diagnostics to help distribute and promote our innovative line of IHC products into the United States,” Alfonso Heras, DVM, PhD, president and CEO of Bio SB, said in a statement. “Our partnership with CDI, coupled with our growing portfolio of FDA/ISO13485:2003 certified IVD detection systems, chromogens, and 130-plus rabbit monoclonal antibodies will help us expand our market share in the U.S.”

Cancer Diagnostics manufactures, develops, and supplies products worldwide for the anatomic pathology market.

Bio SB, 805-692-2768

Cancer Diagnostics, 877-846-5393